ATI Pathophysiology Final Exam Related

Review ATI Pathophysiology Final Exam related questions and content

Medroxyprogesterone acetate (Provera) is indicated for the treatment of women with

  • A. uterine bleeding.
  • B. cervical cancer.
  • C. ovarian cancer.
  • D. fibromyalgia.
Correct Answer: A

Rationale: Medroxyprogesterone acetate (Provera) is commonly used to treat conditions like abnormal uterine bleeding, amenorrhea, and endometriosis. It helps regulate the menstrual cycle and reduce excessive bleeding. Therefore, the correct answer is A. Choice B, cervical cancer, is incorrect because Provera is not indicated for the treatment of cancer. Choice C, ovarian cancer, is also incorrect as Provera is not a primary treatment for ovarian cancer. Choice D, fibromyalgia, is unrelated to the use of medroxyprogesterone acetate.